Company Presentation

Aurealis Therapeutics

Category:Clinical Stage Biotech Company
Time:13:15 – 13:30
Speaker:Juha Yrjänheikki, CEO

Company profile

Aurealis Therapeutics is a Swiss-Nordic clinical stage Cell & Gene Therapy Company. Our multi-therapy platform is based on safe lactic acid bacteria, genetically modified to produce multiple therapeutic proteins in the body: cytokines, growth factors, antibody fragments. We address multi-factorial diseases with large unmet medical needs: Chronic Wounds – Diabetic Foot Ulcers, Venous Ulcers – deadly Cancers – Ovarian Cancer, Peritoneal Carcinomatosis – Inflammation.

Further information

Follow us